Like many other nuclear medicine vendors, SMV of Twinsburg, OH,is developing high-energy imaging technologies to image fluorodeoxyglucose,the radiotracer used in most PET studies. At its RSNA booth, SMVwill display both collimated and coincidence detection-based high-energymethods, according to Robert Ripley, director of corporate communications.
SMV will also debut a new motion-correction program designedto work with its Transmission Attenuation Correction (TAC) productand its Restore resolution recovery algorithm.
